In our study, elevated glycolytic activity in MAFLD was associated with increased CDK1 expression, suggesting that enhanced glycolysis may contribute to the progression from MASH to HCC via CDK1-mediated mechanisms. The gene discussed is CDK1; the disease is hepatocellular carcinoma.